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Abstract
Valproic acid (VPA) has been used clinically as an anticonvulsant medication during pregnancy; however, it poses
a neurodevelopmental risk due to its high teratogenicity. We hypothesized that midgestational (GD) exposure to VPA will
lead to lasting deficits in social behavior and the processing of social stimuli. To test this, animals were given a single IP
injection of 600 mg/kg of VPA on GD 12.5. Starting on postnatal day 2 (PND2), animals were examined for physical and
behavior abnormalities. Functional MRI studies were carried out after PND60. VPA and control animals were given vehicle or
a central infusion of a V1a antagonist 90 minutes before imaging. During imaging sessions, rats were presented with
a juvenile test male followed by a primary visual stimulus (2 Hz pulsed light) to examine the effects of prenatal VPA on
neural processing. VPA rats showed greater increases in BOLD signal response to the social stimulus compared to controls in
the temporal cortex, thalamus, midbrain and the hypothalamus. Blocking the V1a receptor reduced the BOLD response in
VPA animals only. Neural responses to the visual stimulus, however, were lower in VPA animals. Blockade with the V1a
antagonist did not revert this latter effect. Our data suggest that prenatal VPA affects the processing of social stimuli and
perhaps social memory, partly through a mechanism that may involve vasopressin V1a neurotransmission.
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Introduction
Autism spectrum disorders (ASD), which includes autism,
Asperger’s syndrome, and pervasive developmental disorder not
otherwise specified (PD-NOS), are characterized by deficits in
verbal and non-verbal communication, reduced social interac-
tions, and restricted range of interests and motor stereotypies.
Genome-wide screening has identified numerous gene mutations
that might underlie ASD [1]. Among the candidate genes for ASD
are those encoding the arginine-vasopressin (AVP) V1a receptor
(V1AR) [2] and the oxytocin receptor [1], which are known neural
substrates that modulate the expression of social behavior [3,4].
However, a wider range of genes are linked to ASD, which
supports the notion of multiple developmental origins. Despite our
growing knowledge of the genes associated with ASD, research is
needed in order to establish animal models that accurately depict
its underlying neurobiology and multiple origins. Developmental
insults during specific stages of CNS development contribute to the
etiology of ASD. Medications treating depression, hypertension
and epilepsy during pregnancy may increase the risk of fetal
malformations and ASD [5,6,7,8]. These include valproic acid
(VPA), carbamazepine, thalidomide, and phenytoin [9]. Of all the
aforementioned drugs, only VPA results in similar birth defects in
rats and has provided a useful tool to model ASD [9,10,11]. VPA,
which is commercially available as DepakoteH, is a mood stabilizer
and anticonvulsant, given during pregnancy to women suffering
from epilepsy. Fetal exposure at embryonic day E20–E24 can
produce neural tube defects and ASD. In rats, the teratologic
effects similar to those reported in humans are observed when
exposure occurs between E9.5–12.5 [9,12,13,14]. Reports indicate
that VPA treated rats show early signs of developmental
abnormalities. These include a longer latency for eye opening
compared to healthy pups, deficits in olfactory discrimination in
the nest, and problems with motor performance as early as
postnatal days 8–9 (PD8–9) [10]. Deficits in fear condition [15],
eye-blink conditioned reflex [14], and motor stereotypies have also
been reported [16] and are consistent with the notion that VPA
produces motor and cognitive behavioral features in rats partially
resembling ASD. Abnormalities in size of cerebellar [17] and
brainstem auditory nuclei [9] and of motor [14] and sensory
cortical neuron morphology [18] have been reported in rats
treated prenatally with VPA, which parallels postmortem patho-
logical findings in autistics. These data lends support to the use of
the VPA rat model in studies of the neurobiology of ASD.
Despite the growing amount of experiments on the effects of
gestational VPA on neurodevelopment, a detailed investigation of
social neural processing is yet to be carried out. Here, we tested
whether prenatally exposed rats show abnormal behavioral and
neurophysiological responses to social and non-social (visual)
stimuli. The experiments were designed to track the developmen-
tal progress of various social behaviors from the early postnatal
period to adulthood. Given the available evidence cited above, we
anticipated that gestational VPA would dramatically alter the way
the specific brain regions of the rat respond to a social stimulus.
Moreover, the role of vasopressin in modulating the neural
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prenatally to VPA. Genes encoding the vasopressin (AVP) V1a
receptor have been linked to ASD [2]. Within the mammalian
central nervous system, the modulatory actions of AVP are
predominantly mediated by the V1a receptor subtype, which is
distributed throughout several limbic subcortical nuclei in rodent
brain [19]. Recent evidence indicates that neonatal VPA exposure
can influence vasopressin immunolabelling in several regions of
the rodent brain such as the anterior hypothalamic area and
mediodorsal thalamus, and influences olfactory-based social
behavior in rodents [20]. Therefore, it was also hypothesized here
that the role of V1a mediated neurotransmission in the neural
processing of a social stimulus would be altered by gestational
exposure to VPA.
Results
The goal of the present study was to begin to characterize
behavioral and neural alterations relevant to social interactions in
animals that were gestationally exposure to VPA. The dose of
VPA and timing of the treatment was based on previous work
showing behavioral alterations resembling features of ASD [10].
Putative changes in social neural processing and altered social
behavior was the focus of the research. It was anticipated that any
changes in social behavior and brain function would be mediated
in part through an altered functional role of the AVP V1a receptor
subtype. Figures 1,2,3,4 report data for behavioral effects of
gestation VPA exposure, while Figures 5,6,7,8,9,10 report
functional MRI results.
Pup weights and other physical measures of newborn
pups
VPA and saline treated rats did not differ in their overall weights
(Figure S1). Both groups had comparable weight gain. Age of eye
opening and anogenital distances was similar between VPA and
saline pretreated rats. These data suggest that the dose and timing
of gestational VPA treatment did not produce overt structural and
anatomical modifications that are consistent with its role as
a teratogen.
Pup ultrasonic vocalizations (USV’s) in the early-to-mid
neonatal period (PND5 and PND11)
We observed variations in USV call patterns that were
dependent on both gestational VPA treatment and postnatal day
in which the measurements were taken. Data are shown in
Figure 1. Call patterns in rodents have complex frequency and
spectral features. We observed various stereotypical waveform
patterns on spectrograms that were categorized for analysis. A
large majority of USV’s were observed within the 40 kHz range,
although there were calls emitted at higher .50 KHz and at lower
frequencies (,30 kHz). In addition, eight USV types were easily
identifiable. These included complex, two-syllable, frequency
steps, flat, chevron, short, downward and upward types
(Figure 1). Criteria for their classification are provided in Table
S1. The upper row of graphs in Figure 1 shows that complex and
frequency step types increase in quantity on postnatal day (PND)
11 compared with PND5 (complex p=0.0003 and frequency steps
p=0.0002, Kruskall-Wallis ANOVA). VPA treatment did not
alter this increase. However, VPA pretreatment resulted in
a higher level of complex USV calls on PND5 (Figure 1; VPA
Figure 1. Number of ultrasonic vocalizations (USV) emitted by saline (SAL) and valproic acid (VPA) pre-exposed pups. Data were
collected on postnatal days 5 and 11 (D5 and D11). USV’s were categorized and analyzed separately according to specific USV characteristics. Bar
graphs all have representative sonograms overlying the category title. All data presented as mean 6 standard error. *Significantly different from SAL
D5; **significantly different from VPA D5 (Kruskall-Wallis Analysis of Variance, p,0.05). VPA D11 showed a nonsignificant trend when compared to
VPA D5 (p=0.05).
doi:10.1371/journal.pone.0037313.g001
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row of graphs shows that VPA rats had a higher quantity of
downward type USV calls (VPA D5 vs SAL D5; p=0.006,
Kruskall-Wallis ANOVA). This difference was not present by
PND11 (Figure 1 downward type graph). No additional
differences were found in other USV call types. The USV data
therefore indicates that specific types of pup calls, which might
Figure 2. Behavior of adolescent rats pre-exposed to saline or valproic acid (VPA) during gestation. Animals were tested for social
interactions, play behaviors, spontaneous locomotor activity, and self-grooming. Rats showed lower social interaction (t-test t20=2.1, p=0.04) and
greater locomotor activity (t-test t20=2.1, p=0.03). No differences were observed with play behavior and self-grooming. However, play attacks to the
nape were significantly lower in VPA compared with SAL animals (t20=2.1, p=0.04; data not shown). All data shown as mean 6 standard error.
*Significantly different from SAL (two-tailed t-test, p,0.05).
doi:10.1371/journal.pone.0037313.g002
Figure 3. Novel object recognition in rats pre-exposed to saline and valproic acid (VPA) during gestation. Left bar graph shows total
time spent exploring both objects inside a test arena. Middle bar graph shows the time saline treated rats spent exploring a novel versus a familiar
object. Right bar graph shows data for VPA pre-exposed rats. While saline animals spent less time exploring a familiar object (middle), VPA animals
spent equal amounts of time exploring each object (right). This was not associated with overall levels of object exploration (left). Data shown as mean
6 standard error. Asterisks indicate significant differences p,0.05 (two tailed t-test).
doi:10.1371/journal.pone.0037313.g003
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VPA treatment.
Adolescent play-fighting and social behavior (PND35–40)
VPA treated rats showed greater levels of general activity
(locomotor activity) than saline controls (t-test t20=2.1, p=0.03;
Figure 2), but no differences in self-grooming. VPA rats also
showed reduced social interactions with the juvenile intruder rat (t-
test t20=2.1, p=0.04). This included approaching, sniffing,
grooming the intruder. Grouped play fighting showed no
differences between the treatment conditions (Figure 2). Howev-
er, upon categorization we observed reduced movements over the
nape of the intruder by the resident test animal (t-test t20=2.1,
p=0.04; Figure S2). These data provide evidence that VPA
treatment affects social behavior and play fighting during
adolescence.
Novel object recognition (NOR) test
Figure 3 shows the results for a novel object recognition test.
This was included in the battery of tests to confirm whether
cognitive changes occur with gestational VPA exposure. Although
saline and VPA animals did not show differences in general
interactions with the objects inside the cage, saline animals spent
significantly more time exploring (sniffing, establishing contact,
exploring) the novel versus familiar object (t-test t11=2.6,
p=0.04). VPA animals spent an equal amount of time approach-
ing both objects (novel and familiar). Thus, in addition to early life
deficits in social behavior, play fighting and altered USV calls,
VPA exposed rats also show signs of cognitive deficits.
Vasopressin V1a modulation of social interactions in
adulthood
Figure 4 shows the results of a social interaction test carried out
prior to fMRI studies. Two-way ANOVA revealed significant
main effects of both prenatal and pre-imaging treatments on social
interactions (F1,30=6.5,p=0.01) and grooming (F1,30=5.0,
p=0.03), but not locomotor activity (F1,30=3.5, p=0.06). VPA
rats (PND60–65) showed significantly lower interactions with
a juvenile test rat than saline animals (Bonferroni posthoc test,
p=0.04). However, animals that received an ICV infusion of the
V1a antagonist did not show a similar effect (Figure 4). A word of
caution here is warranted, however. The animals were tested
almost immediately following intracerebral cannula placement;
therefore the results could vary if tested following a recovery
period.
fMRI of social neural processing
Functional images were segmented into 101 regions of interest
(ROI’s) for the analysis. Coronal slices (1 mm thickness each)
covered the rostral-caudal extent from the most rostral aspect of
the prefrontal cortex and anterior olfactory nucleus-olfactory bulb
junction to the midbrain/visual cortical areas. Saline (Sal) and
VPA rats were subdivided into animals that were given an ICV
injection of Sal or an AVP V1a receptor antagonist. The groups
are: Sal-CSF (n=10), VPA-CSF (n=8), Sal-V1a (n=13), and
VPA-V1a (n=10). Note the different vehicles used for prenatal
treatments (Sal) and pre-imaging V1a blockade (artificial cerebro-
spinal fluid, CSF). An in vivo social stimulus juvenile was presented
during scanning between repetitions 51–100, with repetitions 1–50
corresponding to baseline acquisitions (see text for details). Two-
dimensional coronal maps are shown in Figure 5 for the four
treatment conditions. The maps correspond to averaged compo-
sites across all subjects within each treatment group. Therefore,
areas showing increases in the blood oxygen level dependent
(BOLD) signal are averages of well-aligned structures. There is
significantly increased BOLD in anterior hippocampal, temporal
cortical medial thalamic and midbrain regions upon presentation
of the juvenile male during scanning. The hue of the red-yellow
pixilated areas indicates the extent or magnitude of activation
within the indicated regions, whereas the spread of the voxels
Figure 4. Social interactions and other behaviors in rats pre-exposed to saline (Sal) and valproic acid (VPA) during gestation.
Measurements were taken immediately before setup for fMRI studies and 60 minutes after an intracerebroventricular (ICV) injection. Experiments
tested whether VPA altered social behavior and neural processing, and if this involves an altered role for the V1a receptor. Thus, Sal and VPA rats were
subdivided into animals that were given an ICV injection of Sal or a vasopressin V1a receptor antagonist. The groups are: Sal-CSF (open bar), VPA-CSF
(close bar), Sal-V1a (diagonal patterned), and VPA- V1a (upward patterned). Data shown as mean 6 standard error. VPA rats showed lower social
interaction (left) and trended towards higher locomotor activity (p=0.07). *Significantly different from Sal-Sal (p,0.05; two way ANOVA).
doi:10.1371/journal.pone.0037313.g004
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(voxels). The temporal cortex, substantia nigra, medial pretectal
area, ventral hippocampal areas show greater magnitude BOLD
signal responses in the VPA-saline group compared to the saline
control animals (Figure 6). Amygdala-hypothalamic areas show
greater volume of activation in saline controls presented with the
social stimulus juvenile male. This pattern of activation was
reduced in VPA animals receiving the ICV antagonist of the V1a
receptor (Figure 5).
Figure 5. Blood oxygen level dependent (BOLD) response to a social stimulus in rats pre-exposed to saline and VPA during
gestation. The study design is as explained in Figure 4. Sal and VPA rats were subdivided into animals that were given an ICV injection of Sal or
a vasopressin V1a receptor antagonist. The groups are: Sal-CSF (n=10), VPA-CSF (n=8), Sal-V1a (n=13), and VPA-V1a (n=10). An in vivo social stimulus
juvenile was presented during scanning between repetitions 51–100, with repetitions 1–50 corresponding to baseline acquisitions (see text for
details). Shown are 2D atlas maps for the different treatment conditions. BOLD maps are composites of 8–13 subject functional scans. Several ROI’s
included in the analysis are indicated in the far left column. Scale bar hue (red-yellow) shown at the bottom indicates the percentage change (from 1–
15%) for areas of increased activity.
doi:10.1371/journal.pone.0037313.g005
Figure 6. Social stimulus-induced changes in BOLD in rats pre-exposed to saline (Sal) and VPA during gestation. The study design is as
explained in Figures 4 and 5. An in vivo social stimulus juvenile was presented during scanning between repetitions 51–100, with repetitions 1–50
corresponding to baseline acquisitions (see text for details). Shown are 2D atlas maps for two treatment conditions (Sal and VPA). Close ups highlight
several ROI’s of saline control and VPA treated animal’s. Scale bar hue (red-yellow) shown at the bottom indicates the percentage change (from 1–
15%) for areas of increased activity. Note predominant yellow hue (indicative of higher activity) pixels in VPA-CSF compared to saline (Sal-CSF).
doi:10.1371/journal.pone.0037313.g006
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revealed a subset of regions that showed greatly increased BOLD
activity (% BOLD signal) in VPA compared to saline controls
(Figure 7). In many of these regions, blockade of V1a receptors
with the antagonist resulted in a reduction of VPA’s effect on brain
BOLD responses (Figures 7 and 8). In the following regions
there was a main significant effect of prenatal treatment and/or
interactions between prenatal and preimaging treatments. These
included the temporal cortex (F3,37=8.1, p=0.006), medial
genticulate nucleus (F3,37=5.9, p=0.02), substantia nigra
(F3,37=10.4, p=0.002), posterior hypothalamus (F3,37=7.2,
p=0.01), medial mammillary nucleus (F3,37=4.5, p=0.04), and
medial pretectal area (F3,37=10.3, p=0.002). Figure 7 rows
show the quantitative data for several of the regions showing the
greater magnitude BOLD responses. There are several areas that
showed a different pattern of activation. These included the
secondary motor cortex, where VPA-V1a animals showed a greater
BOLD response than saline-V1a rats (F3,37=8.6, p=0.005). Basal
amygdala BOLD activation was significantly greater in VPA-CSF
than saline-V1a animals (F3,37=5.7, p=0.02). We also analyzed
the volume of activation with ROI’s and observed that there is
a similar pattern (VPA-associated increases in BOLD and
reduction of this effect with V1a receptor antagonism). These
included the medial pretectal area (F3,37=4.8, p=0.03), entorh-
inal cortex (F3,37=8.2, p=0.006), substantia nigra (F3,37=6.9,
p=0.01) and temporal cortex (F3,37=8.7, p=0.005) (Figure 8).
The neural processing of a social stimulus, under the present
experimental conditions, appears to be altered in VPA animals.
Most areas show a robust increase in BOLD response to a social
stimulus (Figures 7,8). However, blockade of the AVP V1a
receptor reduces this effect in VPA exposed, but not saline
exposed, rats. This, our data suggest that the alterations in BOLD
activity may in part be due to changes in AVP neurotransmission.
fMRI of primary sensory (visual) processing
Given the results on the novel object recognition test (where
animals treated with VPA showed diminished novel object/
familiar object distinction), we tested the BOLD response of the rat
visual system to the presentation of a switch operated flashing
(2 Hz) light emitting diode placed approximately 2.59 away from
the center of the bore, but directly within the animal’s visual plane.
Results are shown in Figures 9,10. There is clear activation of
areas of the visual system, including the visual cortex, lateral
genticulate nucleus and superior colliculus. A close inspection of
the % BOLD time courses revealed a greater BOLD activation in
saline controls compared with VPA animals (one-way repeated
measures ANOVA comparing saline-CSF and VPA-CSF animals,
F1, 550=6.3, p=0.04; no difference observed with VPA-V1a
Figure 7. Social stimulus-induced changes in BOLD in rats pre-exposed to saline (Sal) and VPA during gestation. The study design is as
explained in Figures 4 and 5. Sal and VPA rats were subdivided into animals that were given an ICV injection of Sal or a vasopressin V1a receptor
antagonist. The groups are: Sal-CSF (open bar), VPA-CSF (close bar), Sal-V1a (diagonal patterned), and VPA-V1a (upward patterned). The percent
changes correspond to the averaged timecourse for the stimulus epoch. Graphs show percent change in BOLD across groups for various ROI’s. Data
shown as mean 6 standard error. Asterisks and lines indicate specific posthoc comparisons with * p,0.05 and **p,0.01 (two way ANOVA).
doi:10.1371/journal.pone.0037313.g007
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superior colliculus (p=0.1) or lateral genticulate nucleus (p=0.8)
(Figure 9). Treatment with the V1a antagonist had no effect on
percent change in BOLD over time with light stimulation
(Figure 9). We also analyzed the number of voxels showing
increases in BOLD (volume of BOLD activation). The superior
colliculus showed a reduced number of voxels in V1a antagonist
groups (both saline and VPA rats) compared to their counterparts
(p=0.004) (Figure 10). However, the effect of the V1a antagonist
was not selective for the VPA animals alone. Contrary to our
findings with the social stimulus, there is a reduced (instead of
increased) BOLD activity in response to light in primary visual
cortex of VPA pre-exposed animals. This remained unaffected by
the V1a antagonist (Figures 9 and 10). The V1a antagonist
reduced overall light induced BOLD activity in the superior
colliculus (Figure 10), a region known to contain mRNA
transcripts for the V1a receptor [19].
Discussion
The behavioral data show developmental defects associated
with gestational VPA exposure on cognition, locomotion and
social interactions that is consistent with previous work [10].
Changes in USV patterns were observed between PND5 and
PND11 that were independent of the VPA treatment. USV calls
vary between developmental time points, and partly reflect
underlying neurobiological modifications that need further in-
vestigation [21]. Complex and frequency step USV calls were
greater in PND11 than PND5. Other call types did not change
between postnatal days. VPA’s effect on USV calls seemed specific
Figure 8. Number of voxels in rats pre-exposed to saline (Sal) and VPA during gestation. The study design is as explained in Figures 4 and
5. Sal and VPA rats were subdivided into animals that were given an ICV injection of Sal or a vasopressin V1a receptor antagonist. The groups are: Sal-
CSF (open bar), VPA-CSF (close bar), Sal-V1a (diagonal patterned), and VPA-V1a (upward patterned). Data correspond to voxel counts per ROI that
showed significant BOLD signal increases. Similar to Figure 6, VPA-CSF rats show greater BOLD activation (number of voxels) than Sal-CSF. The V1a
antagonist reduces this effect in VPA rats. Data shown as mean 6 standard error. Asterisks and lines indicate specific posthoc comparisons with *
p,0.05 and **p,0.01 (two way ANOVA).
doi:10.1371/journal.pone.0037313.g008
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calls were observed on PND5, but were not present by PND11.
This effect might be related to postnatal changes in synaptic
activity and neuronal excitability reported recently [22]. USV calls
are therefore modified and this could potentially reflect underlying
alterations in the brain as a result of gestational VPA exposure.
However, these changes appear transitory within the postnatal
developmental period. Play fighting during adolescence was not
significantly affected in our hands, although we did observe
a reduction in attack-like movements to the nape. However,
Figure 9. Visual system BOLD activation in response to 2 Hz flashing LED in rats pre-exposed to saline and VPA during gestation.
The study design is as explained in Figures 4 and 5. Sal and VPA rats were subdivided into animals that were given an ICV injection of Sal or
a vasopressin V1a receptor antagonist. Left column shows BOLD signal time courses for the visual cortex, superior colliculus and lateral genticulate
nucleus. The groups are: Sal-CSF (white circles), VPA-CSF (blue squares), Sal-V1a (green triangles), and VPA-V1a (red inverted triangles). Data shown as
mean 6 standard error. BOLD signal changes in Sal-CSF rats (white circles) were greater in the visual cortex than VPA-CSF rats (p,0.05, repeated
measures ANOVA). Shown on the right are 2D maps at the level of the visual cortex. Scale bar hue (red-yellow) indicates the percentage change (from
1–15%) for areas of increased activity.
doi:10.1371/journal.pone.0037313.g009
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adulthood was lower in VPA animals, while locomotion increased
above control levels. Collectively, the behavioral data from early
postnatal, adolescence and adulthood support an effect of VPA on
social behavior. These results align well with previous reports [10].
Given these findings, we hypothesized that VPA exposure effects
on social behavior may also be accompanied to some extent by
cognitive deficits [10]. We tested a group of animals on a simple
cognitive task to determine whether a form of short-term memory,
in addition to social behavior, was affected by prenatal VPA. We
observed that VPA rats show a defect in NOR, as demonstrated by
a lack of significant difference between the time spent exploring
a novel object versus a previously encountered object. Overall, our
data support an effect of prenatal VPA on social behavior that was
further examined in adult rats that were imaged for their response
to a social stimulus.
Our neuroimaging data also provides evidence of a lasting effect
of prenatal VPA on social neural processing. VPA-exposed rats
show significantly greater BOLD signal responses to a stimulus
juvenile rat than saline control animals. Even though the observed
behavioral changes suggest a deficit, the neural responses to a social
stimulus in VPA rodents were of greater magnitude. This was
observed in several cortical and subcortical limbic regions,
including temporal, secondary motor and entorhinal cortices,
basal region of the amygdala, medial genticulate, posterior
hypothalamus and mammillary nuclei, and the substantia nigra
pars reticulata. We also provided a primary sensory stimulus to
study three brain regions of the visual pathway to examine
whether differences in social neural processing could be attribut-
able to changes in primary sensory processing, albeit through
a specific sensory system. Interestingly, we observed that the
greater activation found with the social stimulus was not observed
with the visual stimulus. Instead, the visual cortex of VPA rats
showed a lower percentage BOLD signal responses that perhaps
occurs as a result of lower neural activity in this region. The effects
of VPA on primary sensory systems were thus distinct from
subcortical and higher order cortical processing of a socially salient
stimulus. While the complex social stimulus generates a greater
BOLD activation in VPA rats compared with controls, the
primary sensory stimulus has an opposite outcome, at least in the
visual cortex.
In order to examine whether VPA-induced effects on social
neural processing could be associated with changes in functionality
activity through the AVP V1a receptor, we included subgroups of
animals that received an ICV injection of an antagonist for this
receptor. A reduction in BOLD activity in these regions was
observed with V1a blockade. The antagonist on its own had no
effect on the pattern of brain activation shown in control animals.
Thus, the effects of V1a blockade seemed to be selective for the
VPA pretreated animals, supporting an effect of prenatal exposure
on vasopressin neurotransmission. Moreover, the effect of the
antagonist was not found to affect primary sensory processing
(visual). Therefore the actions of the antagonist could be
interpreted as occurring in conjunction with VPA-induced deficits
in higher order processing but not primary visual processing.
However, it is important to point out that, as a stimulus, the
juvenile rat presentation paradigm could evoke various forms of
sensory activation and not just visual. In fact, olfactory stimulation
could also account for the differences in the effects of the
antagonist. We did not include the olfactory bulb in our present
MR scanning procedure. The purpose, however, of the alternative
light stimulation was to simply test sensory processing without the
influence of interacting olfactory effects, which would clearly occur
as a result of the presentation of a social stimulus before or after
a scent. Presenting a scent after presentation of the social stimulus
would likely have had a competing effect with unintended
consequences that we avoided during scanning by simply using
a visual stimulus.
Our data are in agreement with the work of Markram and
colleagues [15,18,23,24,25]. They have repeatedly shown in series
of elegant in vitro electrophysiological studies that areas of the
cortex (somatosensory and prefrontal, for example) show a greater
degree of local but not distant synaptic connectivity in VPA
exposed rats compared to controls [18]. These synapses are more
abundant in quantity but show weakened stimulated membrane
conductance [18]. Interestingly, and despite the weaker excitatory
Figure 10. Number of voxels in visual pathway regions of rats pre-exposed to saline and VPA during gestation. The study design is as
explained in Figures 4 and 5. Sal and VPA rats were subdivided into animals that were given an ICV injection of Sal or a vasopressin V1a receptor
antagonist. The groups are: Sal-CSF (open bar), VPA-CSF (close bar), Sal-V1a (diagonal patterned), and VPA-V1a (upward patterned). VPA treatment did
not have the same effect on the visual stimulus as with the social stimulus (VPA-CSF versus Sal-CSF). V1a receptor blockade reduced voxels in superior
colliculus, an area containing a moderate density of V1a receptor mRNA [19], in both Sal and VPA rats. Data shown as mean 6 standard error. Data
shown as mean 6 standard error. Asterisks indicate specific posthoc comparisons with * p,0.05 and **p,0.01 (two way ANOVA).
doi:10.1371/journal.pone.0037313.g010
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term potentiation (LTP) [24]. Both the greater number of local
synapses and the enhanced LTP could represent biological
mechanisms that underlie the hyperresponsive BOLD activity
we observe in VPA animals in the present study. Their results
point to altered cortical wiring with VPA exposure during
gestation, which may affect cognition, emotionality and social
behavior during the lifespan of the rodents [15]. Consistent with
this work, we observed here that VPA animals show greater
BOLD activation in response to a social stimulus. From the
composite 2D maps in Figure 6 it is possible to observe greater
magnitudes of BOLD with reduced volume of activation.
Although not quantitatively examined, this could represent
a pattern that is consistent with the findings of a greater degree
of local but not distant synaptic connectivity in VPA exposed rats
[18]. Our results using the light stimulus could indicate however
that the observed pattern of activity is not uniform across the brain
(Figure 9).
Blocking V1a receptors reduced the BOLD responses to a social
stimulus in VPA exposed animals only. We do not know whether
the number of receptors, the release of AVP, or the number of
fibers containing AVP accounts for the increased activity. The
areas that showed increased effects of VPA and blockade by the
AVP antagonist were not the same as those studied by Markram
and colleagues, which were the prefrontal cortex and somatosen-
sory cortex [18,25]. Our experimental model did not appear to
recruit these regions. But, it could be that the synaptic mechanisms
described in their work involve other areas of the brain, including
those we observe here to be affected by the prenatal exposure. At
a first glance, the brain regions showing significant effects of VPA
and V1a receptor blockade are difficult to piece together into an
actual neural network and an attempt to do so is speculative.
However, there is strong evidence these areas are known to play
roles in social cognition, arousal, attention and motor function, all
behavioral functions affected in ASD. Moreover, the effects of
VPA in the basal region of the amygdala, temporal cortex, medial
genticulate, entorhinal cortex, brings to mind part of the neural
circuitry of contextual fear conditioning [26]. These areas are
perhaps responding to the experimental conditions in these
animals, an effect not seen as robustly in controls. It also could
be that the greater neural activation in response to a social
stimulus is accompanied by high fear levels [15]. Therefore,
sounds associated with a social interaction are perhaps activating
regions involved in fear reactivity [15]. The effects of V1a blockade
observed in other regions such as the temporal cortex, motor
cortex, substantia nigra are likely to be indirect effects of receptors
located in distal afferent sites. Although there is some scant
expression of V1a messenger across various cortical areas, these are
in very low amounts compared to subcortical expression [19]. The
heteregenous expression of V1a mRNA in forebrain and midbrain
regions can account for the results presented here. Some of these
include the posterior hypothalamus/mammillary nuclei, ventral
hippocampus, lateral septum, and regions of the basal ganglia
[19]. However, a study to look at the expression of AVP or the V1a
messenger in the cortex and other subcortical areas of VPA treated
animals would be needed to determine whether AVP activity or its
receptor are increased.
There are several shortcomings of the study and alternative
explanations that should be noted. First and foremost, the in vivo
presentation of stimuli to the rats that was imaged presents a highly
complex picture of brain processing that is limited in its
interpretability. Although it provides a real world examination of
general patterns of brain activity during a social encounter, it is
difficult to tease out the specific sensory systems that are recruited
and the selectivity of the neural pathways involved. Also, while the
acclimatization minimizes motion, the stress associated with
restraint is not entirely removed. In addition to this, the animal
that is used for presentation is likely to also suffer from stress and
distress, which could lead to the emission of vocalizations detected
by the imaged rat. Therefore, the neural activity measured in
response to social stimulus presentation could be associated with
recognition of the social stimulus, but also can reflect the response
to emitted 22 kHz distress calls on the part of the stimulus juvenile
rat, odors associated with the stimulus rat and perhaps visual
stimulation upon presentation of the juvenile. Despite this, the
neural processing, although complex, does involve a recognized
social stimulus, which was a goal of the study design. An adequate
control for the social stimulus, with all of its intricate properties
was not used. This is actually quite difficult since the stimulus not
only presents odors, but also sound and visual stimulation. Future
work should take this into consideration and specific socially
relevant odors for rats (urine as an unconditioned odor or an
alternative conditioned odor) could be appropriate. With regards
to the imaging, there is sufficient evidence that the magnitude of
the BOLD signal is associated with changes in baseline bloodflow,
as well as neural activity [27]. Reductions in basal blood flow
allows for greater magnitude BOLD responses. Similarly, a re-
duction in basal neuronal activity is permissive of greater
magnitude increases in activity, and oxygen metabolism [28,29].
Therefore, the actions of the V1a antagonist could arguably be
associated with reductions in basal neuronal excitability as well as
blood flow. However, in both of these scenarios, the effects of the
antagonist appear specific for the VPA treatment.
Another concern of the present work relates to the behavioral
assessments after cannulation. We carried out a brief behavioral
test after placement of the intracerebral cannula and injection of
the V1a antagonist. The conditions for testing were therefore not
optimal for social recognition testing. The same could be said of
the fMRI studies 90 minutes post cannulation and injection. As
stated above, the fMRI conditions could reflect distressful
conditions that may hinder clear interpretations solely based on
the processing of social stimuli. Also, the fact that the brief NOR
test results show reduced cognitive functionality could indicate that
there are also memory impairments or deficits in sensory
processing in addition to impairments in social neural processing.
This is partly supported by our findings in Figure 9,10. One final
caveat is that a neurochemical correlate clearly showing an
association between the altered role of V1a vasopressin neuro-
transmission was not determined. Future studies will address this
by immunostaining for vasopressin or mRNA studies for the V1a
receptor, which could be informative when compared to the
present imaging results.
As expected, the role of V1a receptors in modulating socially
relevant neural circuits was influenced by prenatal VPA treatment.
This is consistent with the role of the AVP receptor subtype in
social behaviors and could be one substrate affected by VPA.
Further data using neurochemical techniques are needed to
confirm whether AVP or its receptors or both are affected.
Polymorphisms of the V1a receptor gene within its promoter site,
RS3, have been associated with altruistic behavior [30], ASD [31]
and pair bonding behavior in humans [4]. The RS3 long form of
the promoter-repeat sequence is associated with higher altruistic
behavior and greater hippocampal levels of the V1a receptor
mRNA than the RS2 short sequence [30]. The results in humans
partially replicate work in prairie voles [32] by showing that these
microsatellite repeats in V1a 59-flanking region are functionally
related to social bonding in male voles [33]. Knockout mice
lacking the V1a receptor gene show deficits in social memory tests
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of AVP also underlie the expression of anxiety related behaviors in
rodents [35,36]. The role of V1a receptors, and also oxytocin
receptors, in the regulation of emotion, cognition and social
behavior merits further investigation, within the context of the
neurobiology of ASD.
Our results show a greater BOLD response to a social stimulus
in the VPA rat. This is blocked by the AVP V1a receptor
antagonist. Therefore, the greater ‘sensitivity’ to social stimuli
could in part be mediated by excitatory AVP neurotransmission.
The experiments summarized here leaves important unanswered
questions that will be pursued in subsequent research. For instance
what is the precise in utero mechanism through which VPA affects
AVP neurotransmission and neural circuits of social behavior? On
possible mechanism may involve one of VPA’s intracellular
targets. VPA directly binds to HDAC1 to produce inhibitory
effects similar to butyrate. The observed actions of VPA seemed to
be mediated within a finite window of action centered on the
period of neural tube closure. Much like butyrate, VPA binds
reversibly to HDAC enzymes and inhibit their action, thereby
potentially leading to a transient relaxed chromatin state that
favors gene expression. Our present results, far from providing
conclusive mechanisms, provide potential directions in which to
confirm the effects of VPA on social neural circuits, whether the
treatment has lasting effects on the vasopressin system and finally
whether specific chromatin modifications or other molecular
actions in utero occur during development of these systems.
Materials and Methods
Subjects
Long-Evans female rats (175–225 g) were purchased from
Charles River Laboratories (Wilmington, MA). Females were
housed in pairs in a temperature and humidity controlled room
and maintained on a 12 hr light-dark cycle (12L:12D, lights off at
1900 hr). All experiments were carried out between 0900–
1700 hrs. Females were single housed during their pregnancy
and with their litter during the postpartum period. Home cages
consisted of hanging plastic microisolater cages of standard
dimensions with woodchip bedding. Water and Purina rat chow
were provided ad lib. The general design of the study involved the
treatment of timed pregnant rats with saline or VPA during
midgestation and experimental analysis of behavior during early
development, adolescence and adulthood. Functional MRI studies
are performed in control and treated animals during adulthood to
examine alterations in brain regions responsive to social stimuli.
Behavioral assessments were done to confirm whether prenatal
treatment with VPA affects social behavior across various time
points across the lifespan of the animal.
Procedures involving research animals were conducted in
accordance with the guidelines published in the Guide for the
Care and Use of Laboratory Animals and adhere to the Office of
Laboratory Animal Welfare of the National Institutes of Health
and the American Association for Laboratory Animal Science.
The Institutional Animal Care and Use Committee at Northeast-
ern University provided prior approval of the protocols used in this
study.
Drugs
VPA (disodium salt form) and the AVP V1a antagonist [b-
Mercapto-b,b-cyclopentamethylenepropionyl
1, O-me-Tyr
2,
Arg
8]-Vasopressin were purchased from Sigma-Aldrich Chemical
Co. (St. Louis, MO). VPA was prepared by dissolving it in 0.9%
sterile physiological saline solution at a concentration of 250 mg/
mL and was injected intraperitoneal (IP) at a dose of 600 mg/kg
[10]. Control animals received saline injections. The V1a
antagonist was dissolved in artificial cerebrospinal fluid (aCSF;
Harvard Apparatus, Holliston, MA) and injected intracerebroven-
tricularly (ICV) at a dose of 125 ng/10 mL 90 minutes before
imaging experiments. We have successfully used this antagonist
dose and volume in our previous work [37]. Controls rats received
only 10 ml of aCSF. All injections into ventricles were made
unilaterally.
Gestational valproic acid administration
Females were housed overnight with an experienced male
breeder. In order to confirm pregnancy, daily vaginal smears were
examined under a light microscope each morning for the presence
of sperm flagellae. The presence of spermatozoa was designated as
day 1 of gestation (GD1). On GD12.5 (mid-to-late afternoon of the
12
th day) rats were given a single IP injection of VPA. Pregnant
dams were monitored on a daily basis for changes in weight,
changes in health, or in their feeding patterns. After weaning on
postnatal day (PND) 23, offspring were housed in pairs of non-
siblings (same treatment groups were always housed together).
Pups were closely monitored for any signs of physical abnormal-
ities. We tracked weights, anogenital distances, isolation-induced
ultrasonic calls (see below) and the postnatal day of eye opening.
Weights were taken on PND2, 5, 7, 13, 24 and 50. Animals were
tagged on one limb or abdomen using a non-toxic marker pen to
track data for each pup. Markings were refreshed on a daily basis.
Only male offspring were used in these studies. A total of 23 saline
and 18 VPA treated male pups were tested for vocalizations.
These same animals were used in functional neuroimaging studies
as adults. Separate groups of animals were used for adolescent
social behavior (n=14 saline and n=15 VPA) and novel object
recognition (NOR) tests (n=10 saline and n=8 VPA).
Ultrasound vocalization (USV) recordings during the
postnatal period
USV’s were measured on PND 5 and 11. To induce 40-kHz
separation calls, randomly selected pups were isolated from the
nest for 10 min at room temperature (20.8uC to 23.2uC). They
were placed inside a sound attenuation chamber (Med-Associates,
St. Albans, VT). Ultrasonic vocalizations were recorded using
a condenser microphone that is sensitive to frequencies from 10–
250 kHz (model CM16 Avisoft Bioacoustics, Germany). This
microphone is particularly sensitive to the 50 kHz frequency
range. Sound detection and storage was achieved by interfacing
with an UltraSoundGate USB digital-to-analog converter and
amplifier (USG 116, Avisoft). A laptop PC running Avisoft
RECORDER software was used to store acoustic data as .wav files
for analysis of spectral features. USV’s were continuously
monitored using a frequency window between 10–70 kHz and
spectrograms were generated online using a Fast Fourier Trans-
form size of 256, a sampling rate of 140 kHz, 16-bit data format.
Acoustic datasets were imported into SASLab Pro (Avisoft) and
spectrograms were generated during a 2-minute window for the
analysis. Filtering was used to reduce background noise and
a trained observer manually quantified the total number of USV
waveforms on spectrograms. Previously published spectral wave-
form features for neonatal mice and rats were used as a guide to
classify the distinct USV patterns [38,39,40,41,42,43]. These
included the following eight USV call patterns: complex, two-
syllables, upward, downward, chevron, short, frequency steps and
flat calls. Scoring was conducted blind to the gestational treatment
(Table S1 provides the specific criteria). Examples of the USV call
types are shown on Figure 1.
Gestational Valproate and Neural Processing
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37313Adolescent play fighting and social interaction test
Adolescent rats were tested inside their home cage with wood
shavings covering the floor of the cage. All testing was done during
the light phase. We analyzed play fighting, time spent interacting
with a cage intruder of the same strain, age, sex and weight, and
general grooming activity within the home cage. Only subject data
were analyzed for a given session. Color markings on the scruff of
the neck were used to distinguish subjects from intruders. Intruders
were used more than once. All behavior was video recorded,
imported as .avi files to a laptop PC via 1394b firewire connection
using Windows Movie Maker and were analyzed using ODLog
software (Macropod software). Play behavior was scored as
previously reported [44]. Juvenile PND 35–40 rats were socially
isolated 24 hours prior to testing. Control intruder rats were
randomly selected and placed into the resident’s cage (control or
VPA treated) for 10 minutes and behavior recorded. On any given
test trial, resident and intruder juveniles did not differ by more
than 15 grams in body weight. Animals were from different litters
and were not cage mates. We scored the frequency of pinning (one
of the animals is laying on the floor of the test cage with the other
animal standing over him), number of submissions, pulling/biting,
biting on the nape of the neck. The total duration of play fighting,
general social interaction (approaching, sniffing, and grooming the
intruder), self-grooming and spontaneous locomotion were scored.
Novel object recognition (NOR) test
NOR testing consisted of two phases [45]. Rats were first
acclimatized to the test arena to minimize the effects of novelty
stress on behavior. During the habituation phase, each rat freely
explored the empty arena for 10 minutes on 3 separate days (clear
Plexiglas arena 40-cm
3 in size). All internal and external visual
cues were maintained constant across all test days and the same
experimenter collected data on all days. Videos were taken during
the final test trials in which rats were examined for their time spent
interacting with a familiar versus a novel object. The objects that
were selected were clearly distinguishable by size, shape and
color/contrast (but not smell) and were always placed in the same
regions of the test arena during experimental sessions. Objects
were washed between sessions to reduce odor effects during
testing. These were adhered to the floor of the arena using 1-inch
wide double-sided adhesive. During the first test trial, rats were
placed into the test arena containing two identical objects. The
animals remained in the cage for 10 minutes and then returned to
their home cages. Object exploration was quantified as the time
spent (in seconds) in direct interactions with each object in the test
arena (this collectively included sniffing, contact, and facing the
object while in close proximity). They were again re-tested one
hour later in the same arena with one of the two prior objects
(familiar object) removed from its location and replaced with an
alternate non-identical object (novel object). Therefore, during the
second 10-minute trial, rats were presented with a familiar and
a novel object. Rats typically explore the familiar or habituated
object less than a novel object. It was anticipated that animals
spend more time exploring the novel object and failure to do so
would represent failure to retain memory of the familiar object
after 1 hour. However, this could also represent variations in
visual sensory processing, which was tested during fMRI studies.
Functional magnetic resonance imaging
Imaging the neural response to a social stimulus was carried out
as an adaptation of the social recognition test whereby a juvenile
male rodent is first presented in the home cage of the test animal
and then reintroduced in order to examine time spent in social
exploration. This enhances the ability to recognize the intruder
juvenile rodent. The goal was to examine brain activity in response
to a socially relevant and salient stimulus for the rats. Before
imaging, rats were acclimated to restraint for 5 consecutive days as
previously reported [46]. Two days after the last acclimation day,
rats were imaged for their response to a social stimulus and a visual
stimulus light. Functional MRI studies were carried out between
PN60–65 in saline and VPA pre-exposed animals. Subgroups of
animals received a central infusion of a V1a receptor antagonist or
vehicle (CSF) 90 minutes before imaging. Rats were prepared for
imaging as previously reported [47,48]. We used methods to
deliver an acute dose of V1a antagonist before fMRI, 90 minutes
prior scanning, as previously reported [37,49]. Rats were
anesthetized with 2–4% isoflurane, 4% lidocaine cream applied
to the scalp, the skull surface was exposed and the landmark suture
Bregma located. A 26-gauge cannula of polyethylene tubing (PE-
10: inner diameter 0.28 mm, outer diameter 0.61 mm) was
implanted into the lateral cerebral ventricle (1 mm caudal to
Bregma, 2 mm lateral to the midsagittal sinus, and 4 mm ventral
to dura) and secured to the skull with Vetbond (Webster
Veterinary Inc). Figure S3 shows example cannula placements.
Following the 10 ml infusion, and once animals were fully awake,
they were returned to their home cage for ,60 minutes, after
which a 5-minute exposure to a juvenile male rat was done
immediately prior MRI experiment preparations. During this time
interactions with the juvenile test male was recorded. Animals
were subdivided into subgroups as follows: prenatal saline/pre-
imaging CSF (Sal-CSF, n=10), prenatal VPA/pre-imaging CSF
(VPA-CSF, n=8), prenatal saline/pre-imaging V1a blockade (Sal-
V1a, n=13) and prenatal VPA/pre-imaging V1a blockade (VPA-
V1a, n=10). The unequal number of animals per group was
a result of individual subjects showing excess motion artifact
during scanning.
Functional imaging was performed using a T2-weighted fast
spin echo pulse sequence with the following parameters: repetition
time TR=1562 ms, echo time TE=7.5 ms, effective echo time
TEeff=45 ms and an echo train length ETL=16. Geometry was
setup as follows: 12 slices, field of view of 28 mm, 1.0 mm thick
slices with no gaps, data matrix of 64
2 for functional scans and
256
2 for anatomical scans (Thus, the in plane 2D pixel resolution
was 438 mm
2 for functional and 117 mm
2 for anatomical scans). A
full set of 12 coronal slices across the brain was collected at each
effective repetition time of 6 seconds. During imaging sessions
animals were presented with a juvenile rat 30–40 minutes after
initial encounter outside the magnet. In vivo stimulus presentation
was achieved using a clear Plexiglas cylinder fitted to the inner
dimensions of the bore of the MR scanner [48,50]. Previous
studies have shown that there is minimal motion produced by the
introduction of an in vivo stimulus inside the bore of the scanner
[48]. Experiments were performed on a Bruker 7-Tesla magnetic
resonance imager running Paravision 4.0 (Bruker BioSpin
Corporation, Germany) using a rat volume transmit/surface
receive radiofrequency coil system (insightMRI, Shrewsbury,
MA). The entire imaging session included a 6-minute anatomical
scan and two functional scans (10 minutes each) that lasted a total
of about 40–50 minutes. For the social stimulus presentation, 100
repetitions (6 seconds per repetition) were collected and the
stimulus male was presented in a plastic cylinder at repetition 50
[48]. To test whether general sensory processing was affected by
prenatal VPA, a visual light stimulus was used (a 2 Hz flashing
LED). For the nonsocial light presentation, 100 repetitions were
collected and the light was turned on from repetition 50–70.
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Behavioral data in Figure 1 was analyzed using a non-
parametric Kruskall-Wallis analysis of variance (ANOVA), and
Figures 2,3 were analyzed with an unpaired t-test (with Welch’s
correction) comparing the means of saline and VPA treated
animals (significant p,0.05). Social interaction test in Figure 4
was analyzed using a two-way analysis of variance with gestational
treatment (Saline X VPA) and pre-imaging injection (CSF X V1a
antagonist) as independent variables (significant p,0.05). Full
details of the MRI data analysis using in-house software have been
previously reported [48]. Scans were pre-screened for motion and
drift using a priori criteria [48]. Drift was corrected using linear
detrending. Scans showing severe translational motion that was
deemed uncorrectable (.0.110 mm) were discarded. Each subject
was registered to a digital atlas of the rat brain, based on a high-
resolution anatomical scan of an adult-sized rat, and manually
segmented following standard anatomical coordinates (Figure
S3). Statistical t tests are performed on each subject within the
original coordinate system. The baseline period used was 48
repetitions before and 48 repetitions after social stimulus pre-
sentation (for visual fMRI, 20 repetitions preceding the light
stimulus and 20 repetitions after turning on light was used).
Statistical t tests used a 95% confidence level, two-tailed
distribution, and heteroscedastic variance assumptions. In order
to provide a conservative estimate of significance, a false-positive
detection-controlling algorithm is introduced into the analysis
[51]. This ensures that the false-positive detection rate is below our
confidence level of 5% [47]. Statistically significant pixels were
assigned their percentage change values (stimulus mean minus
control mean). Activated voxel numbers and percent signal
changes were exported to Statistical Package for Social Sciences
(SPSS) for statistical comparisons between groups. The number of
voxels per ROI and their corresponding average percent change
values were statistically evaluated using a 262 analysis of variance
(ANOVA a=0.05). Independent variables were prenatal treat-
ment (saline X VPA) and acute treatment before imaging (CSF X
V1a antagonist). Posthoc tests for specific differences between
treatment groups was done using Bonferroni multiple comparison
test (p,0.05).
Supporting Information
Table S1 Classification criteria for ultrasonic calls
emitted by neonatal rats. Calls included the following eight
USV call patterns: complex, two-syllables, upward, downward,
chevron, short, frequency steps and flat calls. Previously published
spectral waveform features for neonatal mice and rats were used as
a guide to classify the distinct USV patterns [38,39,40,41,42,43].
(DOC)
Figure S1 Weight (in grams) gain during the postnatal
period in pups exposed to saline or valproic acid (VPA)
during gestation. Data were collected at various postnatal time
points (PD2, PD7, PD13, PD24). Data shown as mean 6 standard
error. No significant differences were noted between the groups.
(TIF)
Figure S2 Categorized play behaviors in adolescent rats
exposed to saline or valproic acid (VPA) during gesta-
tion. Categories included attacks to the nape, pinning, submis-
sions, pulling and biting. Data shown as mean 6 standard error.
Asterisks indicate significant differences p,0.05 (two tailed t-test).
(TIFF)
Figure S3 Anatomical alignment of scans to an elec-
tronic atlas of the rat brain. The three views show well-
aligned structures. Images on the right panel show examples of
cannula placements. Only animals with good placements inside
the lateral ventricle were included in the study.
(TIFF)
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